HilleVax
HLVX
HLVX was delisted on the 16th of September, 2025.
1 hedge funds and large institutions have $0 invested in HilleVax in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 73 closing their positions.
82.38% less ownership
Funds ownership: 82.73% → 0.36% (-82%)
99% less funds holding
Funds holding: 74 → 1 (-73)
100% less funds holding in top 10
Funds holding in top 10: 5 → 0 (-5)
100% less capital invested
Capital invested by funds: $82.5M → $0 (-$82.5M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 73
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$285K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$21.1M |
| 2 |
TPC
Takeda Pharmaceutical Company
Tokyo,
Japan
|
-$13.4M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
-$9.79M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$4.82M |
| 5 |
LMC
Lightspeed Management Company
Menlo Park,
California
|
-$4.58M |
HLVX Hedge Fund Activity: Q3 2025 in Review
1 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q3 2025, worth a combined $0 — down 100% from $82.5M a quarter earlier.
Sellers outnumbered buyers: 73 funds closed out of HLVX and 0 opened new positions — a net loss of 73 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was XTX Topco, adding an estimated $285K. The largest seller was Frazier Life Sciences Management, exiting entirely with an estimated $21.1M sold.
- 1 institutional investor held HilleVax (HLVX) as of Q3 2025, down from 74 in Q2 2025.
- Funds reported $0 of HilleVax stock for Q3 2025, down 100% quarter-over-quarter.
- 0 funds opened new HilleVax positions in Q3 2025 and 73 closed out, a net change of -73 holders.
- The largest HilleVax buyer in Q3 2025 was XTX Topco, an estimated $285K added.
- The largest HilleVax seller in Q3 2025 was Frazier Life Sciences Management, an estimated $21.1M sold.
Based on aggregated 13F filings for Q3 2025.